US Stock MarketDetailed Quotes

CTXR Citius Pharmaceuticals

Watchlist
  • 0.8100
  • +0.0410+5.33%
Close May 5 16:00 ET
7.96MMarket Cap-0.14P/E (TTM)

Citius Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
22.97%-4.73M
2.96%-28.2M
13.05%-5.91M
12.68%-8.37M
0.85%-7.79M
-27.17%-6.14M
-2.46%-29.06M
-7.39%-6.8M
-24.25%-9.58M
18.75%-7.85M
Net income from continuing operations
-11.38%-10.28M
-21.15%-39.43M
-11.40%-11.08M
-24.70%-10.57M
18.83%-8.54M
-156.88%-9.23M
3.26%-32.54M
-24.44%-9.94M
4.34%-8.48M
-39.21%-10.53M
Depreciation and amortization
7.50%54.84K
7.87%209.61K
7.44%53.69K
7.82%52.85K
8.16%52.07K
8.10%51.01K
8.15%194.32K
8.04%49.97K
8.09%49.02K
8.26%48.14K
Deferred tax
83.50%264.24K
0.00%576K
0.00%144K
0.00%144K
0.00%144K
0.00%144K
0.00%576K
-75.00%144K
--144K
--144K
Other non cash items
----
178.60%284.18K
--1
--109.95K
--98.08K
--76.15K
-73.03%102K
--0
--0
----
Change In working capital
1,261.42%2.71M
57.94%-1.69M
1,942.79%2.33M
52.94%-1.16M
-315.48%-2.61M
91.10%-233.46K
-1,772.40%-4.01M
-180.37%-126.19K
-2,508.46%-2.47M
136.24%1.21M
-Change in inventory
---6.11M
---2.13M
----
----
----
--0
--0
----
----
----
-Change in prepaid assets
-682.72%-145.74K
81.23%-945.39K
2,302.82%1.26M
45.89%-1.08M
-183.52%-1.15M
100.97%25.01K
-4,430.59%-5.04M
8.15%-57.19K
-595.21%-2M
-2,083.45%-405.48K
-Change in payables and accrued expense
1,906.53%8.66M
84.98%1.54M
579.94%2.73M
39.55%-606.89K
-104.30%-103.44K
-24,427.04%-479.49K
23.99%832.86K
-35.15%-568.91K
-1,906.25%-1M
227.58%2.4M
-Change in other current liabilities
-10.67%-58.3K
-10.86%-218.38K
-10.67%-57.15K
-10.93%-54.82K
-10.93%-53.74K
-10.92%-52.68K
-11.14%-196.99K
-10.93%-51.64K
-11.22%-49.42K
-11.22%-48.44K
-Change in other working capital
33.76%366.07K
-81.75%72.04K
-4.57%526.35K
-0.01%579.59K
---1.31M
--273.69K
374.60%394.73K
13.78%551.54K
19.70%579.67K
----
Cash from discontinued investing activities
Operating cash flow
22.97%-4.73M
2.96%-28.2M
13.05%-5.91M
12.68%-8.37M
0.85%-7.79M
-27.17%-6.14M
-2.46%-29.06M
-7.39%-6.8M
-24.25%-9.58M
18.75%-7.85M
Investing cash flow
Cash flow from continuing investing activities
-5M
0
Net other investing changes
----
---5M
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
----
---5M
----
----
----
----
--0
----
----
----
Financing cash flow
Cash flow from continuing financing activities
2.57M
-27.89%9.97M
-545,260.12%-3.75M
0
13.83M
-687
Net common stock issuance
--2.57M
0.04%13.8M
365.17%84.73K
----
----
--0
--13.8M
---31.95K
----
----
Proceeds from stock option exercised by employees
----
--0
----
----
----
----
--31.27K
----
----
----
Net other financing activities
----
---3.83M
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--2.57M
-27.89%9.97M
-545,260.12%-3.75M
-0.58%13.72M
--0
--0
--13.83M
---687
--13.8M
----
Net cash flow
Beginning cash position
-87.72%3.25M
-36.51%26.48M
-46.18%17.91M
-56.79%12.56M
-44.84%20.35M
-36.51%26.48M
-40.47%41.71M
-30.73%33.28M
-47.87%29.07M
-43.62%36.89M
Current changes in cash
64.93%-2.15M
-52.51%-23.23M
-115.55%-14.66M
26.93%5.35M
0.46%-7.79M
-27.17%-6.14M
46.30%-15.23M
-7.40%-6.8M
154.67%4.22M
19.07%-7.82M
End cash Position
-94.59%1.1M
-87.72%3.25M
-87.72%3.25M
-46.18%17.91M
-56.79%12.56M
-44.84%20.35M
-36.51%26.48M
-36.51%26.48M
-30.73%33.28M
-47.87%29.07M
Free cash flow
22.97%-4.73M
2.96%-28.2M
13.05%-5.91M
12.68%-8.37M
0.85%-7.79M
-27.17%-6.14M
-2.46%-29.06M
-7.39%-6.8M
-24.25%-9.58M
18.75%-7.85M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 22.97%-4.73M2.96%-28.2M13.05%-5.91M12.68%-8.37M0.85%-7.79M-27.17%-6.14M-2.46%-29.06M-7.39%-6.8M-24.25%-9.58M18.75%-7.85M
Net income from continuing operations -11.38%-10.28M-21.15%-39.43M-11.40%-11.08M-24.70%-10.57M18.83%-8.54M-156.88%-9.23M3.26%-32.54M-24.44%-9.94M4.34%-8.48M-39.21%-10.53M
Depreciation and amortization 7.50%54.84K7.87%209.61K7.44%53.69K7.82%52.85K8.16%52.07K8.10%51.01K8.15%194.32K8.04%49.97K8.09%49.02K8.26%48.14K
Deferred tax 83.50%264.24K0.00%576K0.00%144K0.00%144K0.00%144K0.00%144K0.00%576K-75.00%144K--144K--144K
Other non cash items ----178.60%284.18K--1--109.95K--98.08K--76.15K-73.03%102K--0--0----
Change In working capital 1,261.42%2.71M57.94%-1.69M1,942.79%2.33M52.94%-1.16M-315.48%-2.61M91.10%-233.46K-1,772.40%-4.01M-180.37%-126.19K-2,508.46%-2.47M136.24%1.21M
-Change in inventory ---6.11M---2.13M--------------0--0------------
-Change in prepaid assets -682.72%-145.74K81.23%-945.39K2,302.82%1.26M45.89%-1.08M-183.52%-1.15M100.97%25.01K-4,430.59%-5.04M8.15%-57.19K-595.21%-2M-2,083.45%-405.48K
-Change in payables and accrued expense 1,906.53%8.66M84.98%1.54M579.94%2.73M39.55%-606.89K-104.30%-103.44K-24,427.04%-479.49K23.99%832.86K-35.15%-568.91K-1,906.25%-1M227.58%2.4M
-Change in other current liabilities -10.67%-58.3K-10.86%-218.38K-10.67%-57.15K-10.93%-54.82K-10.93%-53.74K-10.92%-52.68K-11.14%-196.99K-10.93%-51.64K-11.22%-49.42K-11.22%-48.44K
-Change in other working capital 33.76%366.07K-81.75%72.04K-4.57%526.35K-0.01%579.59K---1.31M--273.69K374.60%394.73K13.78%551.54K19.70%579.67K----
Cash from discontinued investing activities
Operating cash flow 22.97%-4.73M2.96%-28.2M13.05%-5.91M12.68%-8.37M0.85%-7.79M-27.17%-6.14M-2.46%-29.06M-7.39%-6.8M-24.25%-9.58M18.75%-7.85M
Investing cash flow
Cash flow from continuing investing activities -5M0
Net other investing changes -------5M--------------------------------
Cash from discontinued investing activities
Investing cash flow -------5M------------------0------------
Financing cash flow
Cash flow from continuing financing activities 2.57M-27.89%9.97M-545,260.12%-3.75M013.83M-687
Net common stock issuance --2.57M0.04%13.8M365.17%84.73K----------0--13.8M---31.95K--------
Proceeds from stock option exercised by employees ------0------------------31.27K------------
Net other financing activities -------3.83M--------------------------------
Cash from discontinued financing activities
Financing cash flow --2.57M-27.89%9.97M-545,260.12%-3.75M-0.58%13.72M--0--0--13.83M---687--13.8M----
Net cash flow
Beginning cash position -87.72%3.25M-36.51%26.48M-46.18%17.91M-56.79%12.56M-44.84%20.35M-36.51%26.48M-40.47%41.71M-30.73%33.28M-47.87%29.07M-43.62%36.89M
Current changes in cash 64.93%-2.15M-52.51%-23.23M-115.55%-14.66M26.93%5.35M0.46%-7.79M-27.17%-6.14M46.30%-15.23M-7.40%-6.8M154.67%4.22M19.07%-7.82M
End cash Position -94.59%1.1M-87.72%3.25M-87.72%3.25M-46.18%17.91M-56.79%12.56M-44.84%20.35M-36.51%26.48M-36.51%26.48M-30.73%33.28M-47.87%29.07M
Free cash flow 22.97%-4.73M2.96%-28.2M13.05%-5.91M12.68%-8.37M0.85%-7.79M-27.17%-6.14M-2.46%-29.06M-7.39%-6.8M-24.25%-9.58M18.75%-7.85M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More